Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

The role of dopamine in risk taking: a specific look at Parkinson's disease and gambling.

Clark CA, Dagher A.

Front Behav Neurosci. 2014 May 30;8:196. doi: 10.3389/fnbeh.2014.00196. eCollection 2014. Review.

2.

Dopamine agonists and risk: impulse control disorders in Parkinson's disease.

Voon V, Gao J, Brezing C, Symmonds M, Ekanayake V, Fernandez H, Dolan RJ, Hallett M.

Brain. 2011 May;134(Pt 5):1438-46. doi: 10.1093/brain/awr080.

3.

At-risk for pathological gambling: imaging neural reward processing under chronic dopamine agonists.

Abler B, Hahlbrock R, Unrath A, Grön G, Kassubek J.

Brain. 2009 Sep;132(Pt 9):2396-402. doi: 10.1093/brain/awp170. Epub 2009 Jun 30.

PMID:
19567700
4.

Deep brain stimulation of the subthalamic nucleus transiently enhances loss-chasing behaviour in patients with Parkinson's disease.

Rogers RD, Wielenberg B, Wojtecki L, Elben S, Campbell-Meiklejohn D, Schnitzler A.

Exp Neurol. 2011 Sep;231(1):181-9. doi: 10.1016/j.expneurol.2011.06.007. Epub 2011 Jun 25.

PMID:
21726554
5.

Decisions under risk in Parkinson's disease: preserved evaluation of probability and magnitude.

Sharp ME, Viswanathan J, McKeown MJ, Appel-Cresswell S, Stoessl AJ, Barton JJ.

Neuropsychologia. 2013 Nov;51(13):2679-89. doi: 10.1016/j.neuropsychologia.2013.08.008. Epub 2013 Aug 15.

PMID:
23954375
6.

Decision-making, reward-seeking behaviors and dopamine agonist therapy in restless legs syndrome.

Bayard S, Langenier MC, Dauvilliers Y.

Sleep. 2013 Oct 1;36(10):1501-7. doi: 10.5665/sleep.3044.

7.

Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study.

Steeves TD, Miyasaki J, Zurowski M, Lang AE, Pellecchia G, Van Eimeren T, Rusjan P, Houle S, Strafella AP.

Brain. 2009 May;132(Pt 5):1376-85. doi: 10.1093/brain/awp054. Epub 2009 Apr 3.

8.

Attenuated neural response to gamble outcomes in drug-naive patients with Parkinson's disease.

van der Vegt JP, Hulme OJ, Zittel S, Madsen KH, Weiss MM, Buhmann C, Bloem BR, Münchau A, Siebner HR.

Brain. 2013 Apr;136(Pt 4):1192-203. doi: 10.1093/brain/awt027. Epub 2013 Feb 26.

PMID:
23442226
9.

Medication-related impulse control and repetitive behaviors in Parkinson's disease.

Voon V, Potenza MN, Thomsen T.

Curr Opin Neurol. 2007 Aug;20(4):484-92. Review.

PMID:
17620886
10.

[Dopamine dysregulation syndrome in Parkinson's disease and restless legs syndrome].

Bayard S, Cochen De Cock V, Dauvillers Y.

Geriatr Psychol Neuropsychiatr Vieil. 2011 Jun;9(2):227-35. doi: 10.1684/pnv.2011.0275. Review. French.

PMID:
21690031
11.

Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients.

Bódi N, Kéri S, Nagy H, Moustafa A, Myers CE, Daw N, Dibó G, Takáts A, Bereczki D, Gluck MA.

Brain. 2009 Sep;132(Pt 9):2385-95. doi: 10.1093/brain/awp094. Epub 2009 May 4.

12.

Clinical aspects of impulsive compulsive behaviours in Parkinson's disease.

Djamshidian A, Averbeck BB, Lees AJ, O'Sullivan SS.

J Neurol Sci. 2011 Nov 15;310(1-2):183-8. doi: 10.1016/j.jns.2011.07.031. Epub 2011 Aug 11. Review.

PMID:
21839478
13.

Pathological gambling in Parkinson's disease: what are the risk factors and what is the role of impulsivity?

Heiden P, Heinz A, Romanczuk-Seiferth N.

Eur J Neurosci. 2017 Jan;45(1):67-72. doi: 10.1111/ejn.13396. Epub 2016 Oct 1. Review.

14.

Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease.

Fenu S, Wardas J, Morelli M.

Behav Pharmacol. 2009 Sep;20(5-6):363-79. doi: 10.1097/FBP.0b013e32833109a0. Review.

PMID:
19724195
15.

Impulsive and compulsive behaviors in Parkinson's disease.

Evans AH, Strafella AP, Weintraub D, Stacy M.

Mov Disord. 2009 Aug 15;24(11):1561-70. doi: 10.1002/mds.22505. Review.

PMID:
19526584
16.

Anhedonia in Parkinson's disease patients with and without pathological gambling: a case-control study.

Pettorruso M, Martinotti G, Fasano A, Loria G, Di Nicola M, De Risio L, Ricciardi L, Conte G, Janiri L, Bentivoglio AR.

Psychiatry Res. 2014 Feb 28;215(2):448-52. doi: 10.1016/j.psychres.2013.12.013. Epub 2013 Dec 16.

PMID:
24373553
17.

Impulse Control Disorders and Related Complications of Parkinson's Disease Therapy.

Lopez AM, Weintraub D, Claassen DO.

Semin Neurol. 2017 Apr;37(2):186-192. doi: 10.1055/s-0037-1601887. Epub 2017 May 16.

PMID:
28511259
18.

Past smoking and current dopamine agonist use show an independent and dose-dependent association with impulse control disorders in Parkinson's disease.

Valença GT, Glass PG, Negreiros NN, Duarte MB, Ventura LM, Mueller M, Oliveira-Filho J.

Parkinsonism Relat Disord. 2013 Jul;19(7):698-700. doi: 10.1016/j.parkreldis.2013.03.004. Epub 2013 Apr 20.

PMID:
23611687
19.

Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors.

Voon V, Pessiglione M, Brezing C, Gallea C, Fernandez HH, Dolan RJ, Hallett M.

Neuron. 2010 Jan 14;65(1):135-42. doi: 10.1016/j.neuron.2009.12.027.

20.

Parallel appearance of compulsive behaviors and artistic creativity in Parkinson's disease.

Joutsa J, Martikainen K, Kaasinen V.

Case Rep Neurol. 2012 Jan;4(1):77-83. doi: 10.1159/000338759. Epub 2012 May 9.

Supplemental Content

Support Center